Investor Presentaiton
Investor Presentation
First nine months of 2018
The GLP-1 segment accounts for 14% of the global
diabetes care market value
Slide 71
Global GLP-1 market
GLP-1 value
in bDKK
VictozaⓇ
Exenatide
OzempicⓇ
Other
Share of total
Share of total
diabetes care
diabetes care
GLP-1 value and patient share of the total
diabetes care market
GLP-1 value share of total diabetes
GLP-1 patient share¹ of total diabetes
Dulaglutide
market
market
80
10%
20%
70
16%
8%
60
CAGR value¹: 34.3%
15%
14%
12%
50
- 6%
401
10%
- 4%
30
7%
6%
6%
5%
20
5%
3%
2%
10
1%
0
0%
0%
Aug
2013
Aug
World
2018
North Reg EU Reg Reg J&K Reg
America
LATAM
AAMEO
Reg
China
1 CAGR for 5-year period
Source: IQVIA monthly MAT Aug, 2018 value figures (DKK)
changing
diabetes®
Reg: Region; AAMEO: Africa, Asia, the Middle-East and Oceania; J&K: Japan & Korea; LATAM: Latin America
1 Patient share is indicative and based on data for the USA, the UK, Germany and France only.
Source: Value data; IQVIA monthly MAT Aug, 2018. Patient data; IQVIA Disease Analyser (DE, FR, UK),
Quintiles IQVIA LRX (USA), Aug 2018View entire presentation